1 terminated. 1 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 1 | Terminated 1 |
Follow VTX-2337: new trials by email Literature Review of VTX-2337 trials Research Report on VTX-2337
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Intratumoral Microdosing of Motolimod in HNSCC Motolimod, Nivolumab, Motolimod + Nivolumab - HNSCC | Early Phase 1 | Terminated | Presage Biosciences | 1 | 2021-10-15 | 2022-04-14 |
Head and Neck Neoplasms (1) · Squamous Cell Carcinoma of Head and Neck (1)
United States (1)